X

Trial Profile

Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clopidogrel (Primary) ; Aspirin
Indications Embolism and thrombosis; Stroke
Focus Therapeutic Use
Acronyms SPS3

Most Recent Events

06 Mar 2023 Results of post hoc analysis (n=2874) assessing the rate of persistent smoking after ischemic stroke and the association between smoking status and major cardiovascular outcomes published in the Stroke
22 Jan 2021 Results (n=942) assessing relationship between A1C and cognitive function in lacunar stroke patients with diabetes, published in the Journal of Clinical Endocrinology and Metabolism.
20 Jul 2017 Results (n=2916) assessing cognitive function, presented at the Alzheimer's Association International Conference 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com